<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9094628" created="22/07/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9094628</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Physical interactions between <cons id="T1" lex="(AND Ets_protein NF-kappaB/NFAT_protein)" sem="(AND Protein_family_or_group Protein_family_or_group)"><frag id="F1">Ets</frag> and <frag id="F2">NF-kappaB/NFAT</frag> <frag id="F3">proteins</frag></cons> play an important role in their cooperative activation of the <term id="T2" lex="human_immunodeficiency_virus_enhancer" sem="DNA_domain_or_region">human immunodeficiency virus enhancer</term> in <term id="T3" lex="T_cell" sem="Cell_natural">T cells</term>.</sentence>
<event id="E1">
<type class="Binding"/>
<theme idref="F1" idref1="F3"/>
<theme idref="F2" idref1="F3"/>
<clue><clueType>Physical interactions</clueType> <linkTheme>between</linkTheme> Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells.</clue>
</event>
<event id="E3">
<type class="Positive_regulation"/>
<theme idref="T2"/>
<cause idref="F1" idref1="F3"/>
<cause idref="F2" idref1="F3"/>
<clue>Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in <corefCause>their</corefCause> <clueType>cooperative activation</clueType> <linkTheme>of</linkTheme> the human immunodeficiency virus enhancer <clueLoc>in T cells.</clueLoc></clue>
</event>
<event id="E5">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="E1"/>
<clue>Physical interactions between Ets and NF-kappaB/NFAT proteins <clueType>play</clueType> an <clueType>important role</clueType> in their cooperative activation of the human immunodeficiency virus enhancer in T cells.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term id="T4" lex="transcriptional_regulatory_element" sem="DNA_domain_or_region">transcriptional regulatory elements</term> of many <term id="T5" lex="inducible_T-cell_gene" sem="DNA_family_or_group">inducible T-cell genes</term> contain adjacent or <term id="T6" lex="overlapping_binding_site" sem="DNA_domain_or_region">overlapping binding sites</term> for the <cons id="T7" lex="(AND Ets_family NF-kappaB/NFAT_family)" sem="(AND Protein_family_or_group Protein_family_or_group)"><frag id="F4">Ets</frag> and <frag id="F5">NF-kappaB/NFAT</frag> <frag id="F6">families</frag></cons> of <term id="T8" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term>.</sentence>
<sentence id="S3">Similar arrays of functionally important <cons id="T9" lex="(AND NF-kappaB/NFAT_binding_site Ets_binding_site)" sem="(AND DNA_domain_or_region DNA_domain_or_region)"><frag id="F7">NF-kappaB/NFAT</frag> and <frag id="F8">Ets</frag> <frag id="F9">binding sites</frag></cons> are present in the <term id="T10" lex="transcriptional_enhancer" sem="DNA_domain_or_region">transcriptional enhancers</term> of <cons id="T11" lex="(AND human_immunodeficiency_virus_type_1 human_immunodeficiency_virus_type_2)" sem="(AND Virus Virus)"><frag id="F10">human immunodeficiency viruses types</frag> <frag id="F11">1</frag> and <frag id="F12">2</frag></cons> (<term id="T12" lex="HIV-1" sem="Virus">HIV-1</term> and <term id="T13" lex="HIV-2" sem="Virus">HIV-2</term>), suggesting that this <term id="A4" sem="Other">pattern of <term id="T14" lex="nuclear_protein_binding_site" sem="DNA_domain_or_region">nuclear protein binding sites</term></term> reflects an evolutionarily conserved mechanism for regulating inducible <term id="T15" lex="T-cell_gene_expression" sem="Other">T-cell gene expression</term> that has been co-opted during <term id="T16" lex="HIV_evolution" sem="Other">HIV evolution</term>.</sentence>
<event CL="L2" KT="Analysis" id="E7">
<type class="Regulation"/>
<theme idref="T15"/>
<cause idref="A4"/>
<clue>Similar arrays of functionally important NF-kappaB/NFAT and Ets binding sites are present in the transcriptional enhancers of human immunodeficiency viruses types 1 and 2 (HIV-1 and HIV-2), <clueKT><clueCL>suggesting</clueCL></clueKT> that this pattern of nuclear protein binding sites reflects an evolutionarily conserved mechanism for <clueType>regulating</clueType> inducible T-cell gene expression that has been co-opted during HIV evolution.</clue>
<comment>TPS: A4</comment></event>
<sentence id="S4">Despite these findings, the <term id="T17" lex="molecular_mechanism" sem="Other">molecular mechanisms</term> by which <cons id="T18" lex="(AND Ets_protein NF-kappaB/NFAT_protein)" sem="(AND Protein_family_or_group Protein_family_or_group)"><frag id="F13">Ets</frag> and <frag id="F14">NF-kappaB/NFAT</frag> <frag id="F15">proteins</frag></cons> cooperatively regulate inducible <term id="T19" lex="T-cell_gene_expression" sem="Other">T-cell gene expression</term> remained unknown.</sentence>
<event KT="Fact" id="E8">
<type class="Regulation"/>
<theme idref="T19"/>
<cause idref="F13" idref1="F15"/>
<cause idref="F14" idref1="F15"/>
<clue>Despite these findings, the molecular mechanisms by which Ets and NF-kappaB/NFAT proteins <clueType>cooperatively regulate</clueType> inducible T-cell gene expression remained unknown.</clue>
</event>
<sentence id="S5">In the studies described in this report, we demonstrated a physical interaction between multiple <cons id="T20" lex="(AND Ets_protein NF-kappaB/NFAT_protein)" sem="(AND Protein_family_or_group Protein_family_or_group)"><frag id="F16">Ets</frag> and <frag id="F17">NF-kappaB/NFAT</frag> <frag id="F18">proteins</frag></cons> both in vitro and in <term id="T21" lex="activated_normal_human_T_cell" sem="Cell_natural">activated normal human <term id="T22" lex="T_cell" sem="Cell_natural">T cells</term></term>.</sentence>
<event id="E10">
<type class="Binding"/>
<theme idref="F16" idref1="F18"/>
<theme idref="F17" idref1="F18"/>
<clue>In the studies described in this report, we <clueKT>demonstrated</clueKT> a <clueType>physical interaction</clueType> <linkTheme>between</linkTheme> multiple Ets and NF-kappaB/NFAT proteins both in vitro and <clueLoc>in activated normal human T cells.</clueLoc></clue>
</event>
<event KT="Method" id="E12">
<type class="Physiological_process"/>
<theme idref="T22"/>
<clue>In the studies described in this report, we demonstrated a physical interaction between multiple Ets and NF-kappaB/NFAT proteins both in vitro and in <clueType>activated</clueType> normal human T cells.</clue>
</event>
<sentence id="S6">This interaction is mediated by the <term id="T23" lex="Ets_domain" sem="Protein_domain_or_region">Ets domain</term> of <term id="T24" lex="Ets_protein" sem="Protein_family_or_group">Ets proteins</term> and the C-terminal region of the <term id="A10" sem="Protein_domain_or_region">Rel homology domains</term> of <term id="T25" lex="NF-kappaB/NFAT_protein" sem="Protein_family_or_group">NF-kappaB/NFAT proteins</term>.</sentence>
<event id="E13">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="T23"/>
<clue><corefTheme>This interaction</corefTheme> is <clueType>mediated</clueType> <linkCause>by</linkCause> the Ets domain of Ets proteins and the C-terminal region of the Rel homology domains of NF-kappaB/NFAT proteins.</clue>
<comment>NER T23 MOD</comment></event>
<event id="E51">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="A10"/>
<clue><corefTheme>This interaction</corefTheme> is <clueType>mediated</clueType> <linkCause>by</linkCause> the Ets domain of Ets proteins and the C-terminal region of the Rel homology domains of NF-kappaB/NFAT proteins.</clue>
</event>
<sentence id="S7">In addition, the <term id="T26" lex="Ets-NF-kappaB/NFAT_interaction" sem="Other"><term id="T27" lex="Ets" sem="Protein_molecule">Ets</term>-<term id="A11" sem="Protein_complex"><term id="T28" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>/<term id="T29" lex="NFAT" sem="Protein_family_or_group">NFAT</term></term> interaction</term> requires the presence of <term id="T30" lex="DNA_binding_site" sem="Protein_domain_or_region">DNA binding sites</term> for both proteins, as it is abolished by the <term id="T31" lex="DNA_intercalating_agent" sem="Organic_compound_other">DNA intercalating agents</term> <term id="T32" lex="propidium_iodide" sem="Organic_compound_other">propidium iodide</term> and <term id="T33" lex="ethidium_bromide" sem="Organic_compound_other">ethidium bromide</term> and enhanced by the presence of <term id="A12" sem="Polynucleotide"><term id="T34" lex="synthetic_oligonucleotides" sem="Polynucleotide">synthetic oligonucleotides</term> containing <term id="T35" lex="binding_site" sem="DNA_domain_or_region">binding sites</term> for</term> <term id="T36" lex="Ets" sem="Protein_family_or_group">Ets</term> and <term id="T37" lex="NF-kappaB_protein" sem="Protein_family_or_group">NF-kappaB proteins</term>.</sentence>
<event id="E14">
<type class="Binding"/>
<theme idref="A11"/>
<theme idref="T27"/>
<clue>In addition, the Ets-NF-kappaB/NFAT <clueType>interaction</clueType> requires the presence of DNA binding sites for both proteins, as it is abolished by the DNA intercalating agents propidium iodide and ethidium bromide and enhanced by the presence of synthetic oligonucleotides containing binding sites for Ets and NF-kappaB proteins.</clue>
</event>
<event id="E15">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="T30"/>
<clue>In addition, the Ets-NF-kappaB/NFAT interaction <clueType>requires</clueType> the presence of DNA binding sites for both proteins, as it is abolished by the DNA intercalating agents propidium iodide and ethidium bromide and enhanced by the presence of synthetic oligonucleotides containing binding sites for Ets and NF-kappaB proteins.</clue>
<comment>NER: T30 MOD</comment></event>
<event id="E16">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="T32"/>
<clue>In addition, the Ets-NF-kappaB/NFAT interaction requires the presence of DNA binding sites for both proteins, as it is <clueType>abolished</clueType> <linkCause>by</linkCause> the <corefCause>DNA intercalating agents</corefCause> propidium iodide and ethidium bromide and enhanced by the presence of synthetic oligonucleotides containing binding sites for Ets and NF-kappaB proteins.</clue>
</event>
<event id="E17">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="T33"/>
<clue>In addition, the Ets-NF-kappaB/NFAT interaction requires the presence of DNA binding sites for both proteins, as it is <clueType>abolished</clueType> <linkCause>by</linkCause> the <corefCause>DNA intercalating agents</corefCause> propidium iodide and ethidium bromide and enhanced by the presence of synthetic oligonucleotides containing binding sites for Ets and NF-kappaB proteins.</clue>
</event>
<event id="E18">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="A12" idref1="T36"/>
<clue>In addition, the Ets-NF-kappaB/NFAT interaction requires the presence of DNA binding sites for both proteins, as it is abolished by the DNA intercalating agents propidium iodide and ethidium bromide and <clueType>enhanced</clueType> <linkCause>by</linkCause> the presence of synthetic oligonucleotides containing binding sites for Ets and NF-kappaB proteins.</clue>
<comment>TPS: A12</comment></event>
<event id="E19">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="A12" idref1="T37"/>
<clue>In addition, the Ets-NF-kappaB/NFAT interaction requires the presence of DNA binding sites for both proteins, as it is abolished by the DNA intercalating agents propidium iodide and ethidium bromide and <clueType>enhanced</clueType> <linkCause>by</linkCause> the presence of synthetic oligonucleotides containing binding sites for Ets and NF-kappaB proteins.</clue>
<comment>TPS: A12</comment></event>
<sentence id="S8">A <term id="A13" sem="Protein_molecule">dominant-negative mutant</term> of <term id="T38" lex="NF-kappaB_p50" sem="Protein_molecule">NF-kappaB p50</term> that binds <term id="A14" sem="DNA_molecule">DNA</term> but fails to interact with <term id="T39" lex="Ets_protein" sem="Protein_family_or_group">Ets proteins</term> inhibits the <term id="T40" lex="synergistic_activation" sem="Other">synergistic activation</term> of the <cons id="T41" lex="(AND HIV-1_enhancer HIV-2_enhancer)" sem="(AND DNA_domain_or_region DNA_domain_or_region)"><frag id="F19">HIV-1</frag> and <frag id="F20">HIV-2</frag> <frag id="F21">enhancers</frag></cons> by <term id="T42" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> (<term id="T43" lex="p50" sem="Protein_molecule">p50</term> + <term id="T44" lex="p65" sem="Protein_molecule">p65</term>) and <term id="T45" lex="Ets-1" sem="Protein_molecule">Ets-1</term>, suggesting that physical interaction between <term id="T46" lex="Ets" sem="Protein_family_or_group">Ets</term> and <term id="T47" lex="NF-kappaB_protein" sem="Protein_family_or_group"><term id="T48" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> proteins</term> is required for the <term id="T49" lex="transcriptional_activity" sem="Other">transcriptional activity</term> of the <cons id="T50" lex="(AND HIV-1_enhancer HIV-2_enhancer)" sem="(AND DNA_domain_or_region DNA_domain_or_region)"><frag id="F22">HIV-1</frag> and <frag id="F23">HIV-2</frag> <frag id="F24">enhancers</frag></cons>.</sentence>
<event id="E20">
<type class="Binding"/>
<theme idref="A14"/>
<theme idref="A13" idref1="T38"/>
<clue>A dominant-negative mutant of NF-kappaB p50 that <clueType>binds</clueType> DNA but fails to interact with Ets proteins inhibits the synergistic activation of the HIV-1 and HIV-2 enhancers by NF-kappaB (p50 + p65) and Ets-1, suggesting that physical interaction between Ets and NF-kappaB proteins is required for the transcriptional activity of the HIV-1 and HIV-2 enhancers.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E21">
<type class="Binding"/>
<theme idref="T39"/>
<theme idref="A13" idref1="T38"/>
<clue>A dominant-negative mutant of NF-kappaB p50 that binds DNA but <clueType><cluePolarity>fails</cluePolarity> to interact</clueType> <linkTheme>with</linkTheme> Ets proteins inhibits the synergistic activation of the HIV-1 and HIV-2 enhancers by NF-kappaB (p50 + p65) and Ets-1, suggesting that physical interaction between Ets and NF-kappaB proteins is required for the transcriptional activity of the HIV-1 and HIV-2 enhancers.</clue>
</event>
<event KT="Other" id="E22">
<type class="Positive_regulation"/>
<theme idref="F19" idref1="F21"/>
<cause idref="T43"/>
<cause idref="T44"/>
<cause idref="T45"/>
<clue>A dominant-negative mutant of NF-kappaB p50 that binds DNA but fails to interact with Ets proteins inhibits the <clueType>synergistic activation</clueType> <linkTheme>of</linkTheme> the HIV-1 and HIV-2 enhancers <linkCause>by</linkCause> NF-kappaB (p50 + p65) and Ets-1, suggesting that physical interaction between Ets and NF-kappaB proteins is required for the transcriptional activity of the HIV-1 and HIV-2 enhancers.</clue>
</event>
<event KT="Other" id="E23">
<type class="Positive_regulation"/>
<theme idref="F20" idref1="F21"/>
<cause idref="T43"/>
<cause idref="T44"/>
<cause idref="T45"/>
<clue>A dominant-negative mutant of NF-kappaB p50 that binds DNA but fails to interact with Ets proteins inhibits the <clueType>synergistic activation</clueType> <linkTheme>of</linkTheme> the HIV-1 and HIV-2 enhancers <linkCause>by</linkCause> NF-kappaB (p50 + p65) and Ets-1, suggesting that physical interaction between Ets and NF-kappaB proteins is required for the transcriptional activity of the HIV-1 and HIV-2 enhancers.</clue>
</event>
<event id="E24">
<type class="Negative_regulation"/>
<theme idref="E22"/>
<cause idref="A13"/>
<clue>A dominant-negative mutant of NF-kappaB p50 that binds DNA but fails to interact with Ets proteins <clueType>inhibits</clueType> the synergistic activation of the HIV-1 and HIV-2 enhancers by NF-kappaB (p50 + p65) and Ets-1, suggesting that physical interaction between Ets and NF-kappaB proteins is required for the transcriptional activity of the HIV-1 and HIV-2 enhancers.</clue>
</event>
<event id="E25">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="A13"/>
<clue>A dominant-negative mutant of NF-kappaB p50 that binds DNA but fails to interact with Ets proteins <clueType>inhibits</clueType> the synergistic activation of the HIV-1 and HIV-2 enhancers by NF-kappaB (p50 + p65) and Ets-1, suggesting that physical interaction between Ets and NF-kappaB proteins is required for the transcriptional activity of the HIV-1 and HIV-2 enhancers.</clue>
</event>
<event KT="Other" id="E26">
<type class="Binding"/>
<theme idref="T46"/>
<theme idref="T48"/>
<clue>A dominant-negative mutant of NF-kappaB p50 that binds DNA but fails to interact with Ets proteins inhibits the synergistic activation of the HIV-1 and HIV-2 enhancers by NF-kappaB (p50 + p65) and Ets-1, suggesting that <clueType>physical interaction</clueType> <linkTheme>between</linkTheme> Ets and NF-kappaB proteins is required for the transcriptional activity of the HIV-1 and HIV-2 enhancers.</clue>
</event>
<event KT="Other" id="E27">
<type class="Positive_regulation"/>
<theme idref="T49"/>
<cause idref="F22" idref1="F24"/>
<clue>A dominant-negative mutant of NF-kappaB p50 that binds DNA but fails to interact with Ets proteins inhibits the synergistic activation of the HIV-1 and HIV-2 enhancers by NF-kappaB (p50 + p65) and Ets-1, suggesting that physical interaction between Ets and NF-kappaB proteins is required for the transcriptional activity <linkCause>of</linkCause> the HIV-1 and HIV-2 enhancers.</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Other" id="E28">
<type class="Positive_regulation"/>
<theme idref="T49"/>
<cause idref="F23" idref1="F24"/>
<clue>A dominant-negative mutant of NF-kappaB p50 that binds DNA but fails to interact with Ets proteins inhibits the synergistic activation of the HIV-1 and HIV-2 enhancers by NF-kappaB (p50 + p65) and Ets-1, suggesting that physical interaction between Ets and NF-kappaB proteins is required for the transcriptional activity <linkCause>of</linkCause> the HIV-1 and HIV-2 enhancers.</clue>
<comment>NO CLUETYPE</comment></event>
<event CL="L2" KT="Analysis" id="E29">
<type class="Positive_regulation"/>
<theme idref="E27"/>
<cause idref="E26"/>
<clue>A dominant-negative mutant of NF-kappaB p50 that binds DNA but fails to interact with Ets proteins inhibits the synergistic activation of the HIV-1 and HIV-2 enhancers by NF-kappaB (p50 + p65) and Ets-1, <clueKT><clueCL>suggesting</clueCL></clueKT> that physical interaction between Ets and NF-kappaB proteins is <clueType>required</clueType> <linkTheme>for</linkTheme> the transcriptional activity of the HIV-1 and HIV-2 enhancers.</clue>
</event>
<event CL="L2" KT="Analysis" id="E30">
<type class="Positive_regulation"/>
<theme idref="E28"/>
<cause idref="E26"/>
<clue>A dominant-negative mutant of NF-kappaB p50 that binds DNA but fails to interact with Ets proteins inhibits the synergistic activation of the HIV-1 and HIV-2 enhancers by NF-kappaB (p50 + p65) and Ets-1, <clueKT><clueCL>suggesting</clueCL></clueKT> that physical interaction between Ets and NF-kappaB proteins is <clueType>required</clueType> <linkTheme>for</linkTheme> the transcriptional activity of the HIV-1 and HIV-2 enhancers.</clue>
</event>
<sentence id="S9">Taken together, these findings suggest that evolutionarily conserved physical interactions between <cons id="T51" lex="(AND Ets_protein NF-kappaB/NFAT_protein)" sem="(AND Protein_family_or_group Protein_family_or_group)"><frag id="F25">Ets</frag> and <frag id="F26">NF-kappaB/NFAT</frag> <frag id="F27">proteins</frag></cons> are important in regulating the inducible expression of <term id="T52" lex="T-cell_gene" sem="DNA_family_or_group">T-cell genes</term> and <term id="A23" sem="DNA_domain_or_region">viruses</term>.</sentence>
<event KT="Other" id="E31">
<type class="Binding"/>
<theme idref="F25" idref1="F27"/>
<theme idref="F26" idref1="F27"/>
<clue>Taken together, these findings suggest that evolutionarily conserved <clueType>physical interactions</clueType> <linkTheme>between</linkTheme> Ets and NF-kappaB/NFAT proteins are important in regulating the inducible expression of T-cell genes and viruses.</clue>
</event>
<event KT="Other" id="E32">
<type class="Gene_expression"/>
<theme idref="T52"/>
<clue>Taken together, these findings suggest that evolutionarily conserved physical interactions between Ets and NF-kappaB/NFAT proteins are important in regulating the inducible <clueType>expression</clueType> <linkTheme>of</linkTheme> T-cell genes and viruses.</clue>
</event>
<event KT="Other" id="E33">
<type class="Gene_expression"/>
<theme idref="A23"/>
<clue>Taken together, these findings suggest that evolutionarily conserved physical interactions between Ets and NF-kappaB/NFAT proteins are important in regulating the inducible <clueType>expression</clueType> <linkTheme>of</linkTheme> T-cell genes and viruses.</clue>
</event>
<event CL="L2" KT="Analysis" id="E34" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E32"/>
<cause idref="E31"/>
<clue>Taken together, these findings <clueKT><clueCL>suggest</clueCL></clueKT> that evolutionarily conserved physical interactions between Ets and NF-kappaB/NFAT proteins are important in <clueType>regulating</clueType> the inducible expression of T-cell genes and viruses.</clue>
</event>
<event CL="L2" KT="Analysis" id="E35" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E33"/>
<cause idref="E31"/>
<clue>Taken together, these findings <clueKT><clueCL>suggest</clueCL></clueKT> that evolutionarily conserved physical interactions between Ets and NF-kappaB/NFAT proteins are important in <clueType>regulating</clueType> the inducible expression of T-cell genes and viruses.</clue>
</event>
<sentence id="S10">These interactions represent a potential target for the development of novel <cons id="T53" lex="(AND immunosuppressive_therapy antiviral_therapy)" sem="(AND Other Other)"><frag id="F28">immunosuppressive</frag> and <frag id="F29">antiviral</frag> <frag id="F30">therapies</frag></cons>.</sentence>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
